This content is machine translated AID systems in childhood and adolescence Technology for everyone? Type 1 diabetes is one of the most common metabolic diseases in children and adolescents. A diagnosis of type 1 diabetes is a considerable burden for those affected and their… CME-Test
View Post 11 min This content is machine translated Shared decision making Participatory decision-making using the example of diets for type 1 diabetes Participatory decision-making (PEF for short) has established itself in recent decades as a desirable form of interaction between doctor and patient. The concept is primarily based on the ethical principles… CME-Test
View Post 11 min This content is machine translated Shared decision making Participatory decision-making using the example of diets for type 1 diabetes Participatory decision-making (PEF for short) has established itself in recent decades as a desirable form of interaction between doctor and patient. The concept is primarily based on the ethical principles… CME-Test
View Post 4 min This content is machine translated Type 2 diabetes ESC recommendations for reducing cardiovascular risk Patients with type 2 diabetes have a greatly increased risk of developing cardiovascular disease compared to healthy people in the same age group. The current guidelines published in the European…
View Post 5 min This content is machine translated Renal insufficiency in general practice Improve early detection and inhibit progression The most common causes of chronic kidney disease (CKD) include diabetes and hypertension. Regular screening is recommended if there is an increased risk of CKD. In addition to the eGFR,…
View Post 10 min This content is machine translated Diabetic foot syndrome Exercise and DFS – does every step make you fit? Regular physical activity and increasing physical activity are part of the basic therapy for the treatment of type 2 diabetes in national and international guidelines. With structured aerobic exercise training,… CME-Test
View Post 9 min This content is machine translated Update ESC Guidelines 2023 Detailed recommendations for cardiovascular diseases in diabetes The updated guideline recommends important innovations in the areas of screening, cardiovascular risk assessment in diabetes mellitus and aspects of evidence-based cardiovascular risk reduction in type 2 diabetes patients with…
View Post 3 min This content is machine translated Type 2 diabetes: PIONEER REAL Switzerland study Semaglutide in oral form convinces in everyday practice In the non-interventional PIONEER REAL Switzerland study, adult type 2 diabetics treated with oral semaglutide as part of routine clinical care achieved clinically significant improvement in glycemic control with no…
View Post 3 min This content is machine translated Myasthenia gravis Something is happening in the treatment management of autoimmune diseases Myasthenia gravis (or myasthenia for short) is a rare disease in which the immune system turns against its own body. Autoantibodies disrupt the transmission of impulses at the interface between…
View Post 10 min This content is machine translated GLP-1 agonists continue to gain ground Semaglutide in patients with obesity and heart failure It has long been known that the active ingredient class of glucagon-like peptide-1 agonists (GLP-1) reduces cardiovascular consequences in diabetics and leads to significant weight loss in patients with obesity.…
View Post 4 min This content is machine translated SGLT-2-i in type 2 diabetes and CVD Cardioprotective mechanisms of action of empagliflozin – what’s new? Empagliflozin is known to reduce the risk of atherosclerotic cardiovascular disease (CVD) in people with type 2 diabetes and high cardiovascular risk. The mechanisms underlying these effects are not yet…
